MAC
74
4
AEE
50
2
MMM
33
7
ETR
49
2
DVN
28
3
SBUX
33
-3
SRE
38
-14
INTC
47
4
GRMN
64
2
PFG
46
-2
ACN
38
-2
NSC
45
-3
PCG
88
11
MO
42
-6
BWA
38
-2
VRSK
89
2
ADBE
68
8
CSX
48
-2
DO
49
2
EXPE
62
-4
MAC
74
4
AEE
50
2
MMM
33
7
ETR
49
2
DVN
28
3
SBUX
33
-3
SRE
38
-14
INTC
47
4
GRMN
64
2
PFG
46
-2
ACN
38
-2
NSC
45
-3
PCG
88
11
MO
42
-6
BWA
38
-2
VRSK
89
2
ADBE
68
8
CSX
48
-2
DO
49
2
EXPE
62
-4
Financhill
Back

ProShares Nasdaq-100 High Income ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
19

IQQQ
ProShares Nasdaq-100 High Income ETF

Last Price:
43.00
Seasonality Move:
--
Sell
47

RARE
Ultragenyx Pharmaceutical

Last Price:
41.06
Seasonality Move:
-0.9%
Sell
19
ProShares Nasdaq-100 High Income ETF (IQQQ) is a Sell

Is ProShares Nasdaq-100 High Income ETF a Buy, Sell or Hold?

  • The current ProShares Nasdaq-100 High Income ETF [IQQQ] share price is $42.81. The Score for IQQQ is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • IQQQ is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
47
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IQQQ Stock Price Chart

What is ProShares Nasdaq-100 High Income ETF's stock price today?

  • The ProShares Nasdaq-100 High Income ETF share price today is $42.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IQQQ is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $41.42
    The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

IQQQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.55 Buy
Relative Strength Index (14 RSI): 65.93 Buy
Chaikin Money Flow: -128 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.05 - 42.59) Buy
Bollinger Bands (100): ( - ) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 52.47 Buy
Chaikin Money Flow: 873891 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Buy
Bollinger Bands (100): (40.78 - 48.78) Sell

IQQQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.73 Buy
20-day SMA: 41.96 Buy
50-day SMA: 40.75 Buy
200-day SMA: 0 Buy
8-day EMA: 42.59 Buy
20-day EMA: 42.1 Buy
50-day EMA: 27.72 Buy
200-day EMA: 9.9 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.5 Buy
20-day SMA: 40.58 Buy
50-day SMA: 41.51 Sell
200-day SMA: 42.46 Sell
8-day EMA: 40.23 Buy
20-day EMA: 40.49 Buy
50-day EMA: 41.77 Sell
200-day EMA: 43.33 Sell

ProShares Nasdaq-100 High Income ETF Earnings Growth & IQQQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

ProShares Nasdaq-100 High Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):